Friday 12 September 2014

Lilly stomach cancer drug prolongs life in colon cancer study

(Reuters) - Eli Lilly and Co's LLY.N Cyramza stomach-cancer drug prolonged survival of patients with advanced colon cancer in a late-stage study, the U.S. drugmaker said on Friday.


via Reuters: Health News Read More Here..

No comments:

Post a Comment